Furthermore, HER2‐expressing MDA‐MB468 breast cancer cell lines were successfully lysed in vitro by genetically engineered NK‐92‐scFv(FRP5)‐zeta cells producing a humanized CAR based on HER2‐specific antibody FRP5 carrying CD28 and CD3 signalling domain. This evidence concerns the gene CD28 and breast carcinoma.